Kutsch, Nadine (2021). CLL-IPI: valid in the era of oral inhibitors? Blood, 138 (2). S. 106 - 108. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Full text not available from this repository.Abstract
In this issue of Blood, Parikh et al(1) show in their analysis for the first time that the chronic lymphocytic leukemia international prognostic index (CLL-IPI) can predict time to first diagnosis and overall survival (OS) in a cohort of 969 patients with monoclonal B-cell lymphocytosis (MBL) and Rai 0 stage CLL. This might prove to be a very useful tool for the management of these classical watch-and-wait patients who need to bemonitored for progression or disease-related symptoms and potential treatment indication on a regular basis.
| Item Type: | Journal Article | ||||||||
| Creators: |
|
||||||||
| URN: | urn:nbn:de:hbz:38-565628 | ||||||||
| DOI: | 10.1182/blood.2021011937 | ||||||||
| Journal or Publication Title: | Blood | ||||||||
| Volume: | 138 | ||||||||
| Number: | 2 | ||||||||
| Page Range: | S. 106 - 108 | ||||||||
| Date: | 2021 | ||||||||
| Publisher: | AMER SOC HEMATOLOGY | ||||||||
| Place of Publication: | WASHINGTON | ||||||||
| ISSN: | 1528-0020 | ||||||||
| Language: | English | ||||||||
| Faculty: | Unspecified | ||||||||
| Divisions: | Unspecified | ||||||||
| Subjects: | no entry | ||||||||
| Uncontrolled Keywords: |
|
||||||||
| URI: | http://kups.ub.uni-koeln.de/id/eprint/56562 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
 |
View Item |